Ken Fisher's MRNA Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 10,854 shares of Moderna, Inc. (MRNA) worth $760,172, representing 0.00% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in MRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 10,854 shares. Largest reduction occurred in Q4 2024, reducing 6,265 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Moderna (MRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Moderna (MRNA) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +10,854 | New Buy | 10,854 | $70.04 |
| Q4 2024 | -6,265 | Sold Out | 0 | $0.00 |
| Q3 2024 | +6,265 | New Buy | 6,265 | $66.84 |
| Q1 2024 | -2,067 | Sold Out | 0 | $0.00 |
| Q4 2023 | +2,067 | New Buy | 2,067 | $99.46 |
| Q1 2023 | -1,638 | Sold Out | 0 | $0.00 |
| Q4 2022 | +1,638 | New Buy | 1,638 | $179.49 |
| Q3 2022 | -2,136 | Sold Out | 0 | $0.00 |
| Q2 2022 | -64 | Reduce 2.91% | 2,136 | $142.79 |
| Q1 2022 | -385 | Reduce 14.89% | 2,200 | $172.27 |
| Q4 2021 | +319 | Add 14.08% | 2,585 | $254.16 |
| Q3 2021 | -697 | Reduce 23.52% | 2,266 | $384.82 |
| Q2 2021 | +1,371 | Add 86.12% | 2,963 | $234.90 |
| Q1 2021 | -335 | Reduce 17.38% | 1,592 | $130.65 |
| Q4 2020 | +1,927 | New Buy | 1,927 | $104.31 |
Ken Fisher's Moderna Investment FAQs
Ken Fisher first purchased Moderna, Inc. (MRNA) in Q4 2020, acquiring 1,927 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Moderna, Inc. (MRNA) for 15 quarters since Q4 2020.
Ken Fisher's largest addition to Moderna, Inc. (MRNA) was in Q2 2026, adding 10,854 shares worth $760,172.
According to the latest 13F filing for Q2 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 10,854 shares of Moderna, Inc. (MRNA), valued at approximately $760,172.
As of the Q2 2026 filing, Moderna, Inc. (MRNA) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Moderna, Inc. (MRNA) was 10,854 shares, as reported at the end of Q2 2026.